APA (7th ed.) Citation

Parent, E. E., & Kase, A. M. (2022). A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer. Cancers, 14(17), 4276. https://doi.org/10.3390/cancers14174276

Chicago Style (17th ed.) Citation

Parent, Ephraim E., and Adam M. Kase. "A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer." Cancers 14, no. 17 (2022): 4276. https://doi.org/10.3390/cancers14174276.

MLA (9th ed.) Citation

Parent, Ephraim E., and Adam M. Kase. "A Treatment Paradigm Shift: Targeted Radionuclide Therapies for Metastatic Castrate Resistant Prostate Cancer." Cancers, vol. 14, no. 17, 2022, p. 4276, https://doi.org/10.3390/cancers14174276.